Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the efficacy and safety of topical application of
LAS41003 in comparison to LAS189962 and LAS189961 in the treatment of superinfected eczema.